DHS - ETF AI Analysis
Top Page
WisdomTree U.S. High Dividend Fund (DHS)
Rating:71Outperform
Price Target:―
Positive Factors
Solid Recent Performance
The fund has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.
Strong Top Dividend Names
Several of the largest holdings, including major energy, consumer, and technology companies, have delivered strong year-to-date performance that supports the fund’s returns.
Diversified Sector Mix
Holdings are spread across financials, consumer defensive, health care, energy, utilities, and other sectors, which helps reduce the impact if any one industry struggles.
Negative Factors
High U.S. Concentration
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market weakens.
Mixed Performance Among Top Holdings
A few of the largest positions, particularly in health care and communication services, have shown weak year-to-date performance that can drag on overall returns.
Above-Average Expense Ratio
The fund’s expense ratio is higher than many low-cost index ETFs, which slightly reduces the net return investors keep over time.
DHS vs. SPDR S&P 500 ETF (SPY)
AUM1.41B
RegionNorth America
Expense Ratio0.38%
Beta0.46
IssuerWisdomTree
Inception DateJun 16, 2006
Dividend Yield3.23%
Asset ClassEquity
Index TrackedWisdomTree U.S. High Dividend Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume43,605
30 Day Avg. Volume39,231
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
123.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering324
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DHS Summary
The WisdomTree U.S. High Dividend Fund (DHS) is an ETF that follows the WisdomTree U.S. High Dividend Index, focusing on U.S. companies that pay relatively high dividends. It holds many well-known names such as Exxon Mobil and PepsiCo, and spreads investments across sectors like financials, consumer defensive, health care, and energy. Someone might consider DHS if they want regular income from dividends and broad diversification across many stable, established companies. A key risk is that stock prices and dividend payments can go up or down with the market and with changes in company profits.
How much will it cost me?The WisdomTree U.S. High Dividend Fund (DHS) has an expense ratio of 0.38%, meaning you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on high dividend-paying stocks, which requires more research and management. It’s designed for investors seeking income and stability through dividends.
What would affect this ETF?The WisdomTree U.S. High Dividend Fund (DHS) could benefit from stable or rising interest in dividend-paying stocks, especially during periods of economic uncertainty when investors seek reliable income sources. However, it may face challenges if interest rates rise significantly, as higher yields on bonds could make dividend-focused investments less attractive. Additionally, its heavy exposure to sectors like Health Care and Energy means it could be impacted by regulatory changes or fluctuations in commodity prices.
DHS Top 10 Holdings
DHS leans heavily on classic U.S. dividend powerhouses, with energy, telecom, and healthcare doing much of the heavy lifting. Exxon and Chevron have been rising smartly, giving the fund a strong energy backbone, while Verizon and AT&T add steady, cash-rich telecom muscle. On the healthcare side, Merck is pulling its weight, but AbbVie has been lagging and acting like a small anchor on returns. Tobacco names Altria and Philip Morris are more mixed, showing that this high-dividend, U.S.-only portfolio trades some growth sizzle for income-focused stability.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Altria Group | 5.07% | $71.54M | $110.33B | 12.25% | 64 Neutral | |
| AbbVie | 4.30% | $60.80M | $384.56B | 5.44% | 66 Neutral | |
| Exxon Mobil | 4.17% | $58.96M | $706.93B | 42.52% | 74 Outperform | |
| Merck & Company | 4.16% | $58.73M | $297.40B | 38.07% | 80 Outperform | |
| Philip Morris | 4.12% | $58.23M | $257.38B | 4.58% | 61 Neutral | |
| AT&T | 3.83% | $54.05M | $202.95B | 1.79% | 71 Outperform | |
| PepsiCo | 3.38% | $47.70M | $212.23B | 3.75% | 78 Outperform | |
| Verizon | 3.05% | $43.07M | $211.73B | 10.62% | 81 Outperform | |
| Chevron | 2.94% | $41.55M | $412.85B | 22.78% | 71 Outperform | |
| Bristol-Myers Squibb | 2.47% | $34.90M | $123.51B | 1.85% | 78 Outperform |
DHS Technical Analysis
Positive
―
Price Trends
109.22
Negative
104.99
Positive
100.96
Positive
Market Momentum
-0.43
Negative
54.80
Neutral
70.28
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DHS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 108.23, equal to the 50-day MA of 109.22, and equal to the 200-day MA of 100.96, indicating a neutral trend. The MACD of -0.43 indicates Negative momentum. The RSI at 54.80 is Neutral, neither overbought nor oversold. The STOCH value of 70.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DHS.
DHS Peer Comparison
Comparison Results
Performance Comparison
DHS
WisdomTree U.S. High Dividend Fund
109.22
14.24
14.99%
FDVV
Fidelity High Dividend ETF
―
―
―
FVD
First Trust Value Line Dividend Index Fund
―
―
―
FDL
First Trust Morningstar Dividend Leaders Index Fund
―
―
―
SPYD
SPDR Portfolio S&P 500 High Dividend ETF
―
―
―
PEY
Invesco High Yield Equity Dividend Achievers ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents